Print Page  |  Close Window

Investor Overview

NASDAQ: XBIT0.004.30Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
DateTitle 
07/10/18XBiotech Announces First Patient in Phase 2 Study Evaluating Subcutaneous MABp1 in Patients with Hidradenitis SuppurativaPrinter Friendly Version
05/22/18XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic DermatitisPrinter Friendly Version
04/16/18XBiotech Announces Upcoming Phase 2 Clinical Studies in DermatologyPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »